¬ü°ê¥D¬y¤Î¨È¸Ç­¹«~¥«³õ

¦b2000ªº¥þ¬ü¤H¤f´¶¬dÅã¥Ü¨È¸Ç¤H¤f¬°10,242,998¨ä¤¤¦UºØ±Úªº¤ÀªR¦p¤U(¤£¥]§t«Dªk²¾¥Á¡AÆ[¥ú±´¿Ë)


 

   

¡@

¡@

¡@


                  ¨È¸Ç¤À¥¬±¡ªp

¡@

¦a°Ï

 ¼Æ¶q

¤ñ¨Ò

ªF¥_³¡

    2,868,297.00

4.40%

¤¤¦è³¡

    1,392,938.00

2.20%

«n³¡

    2,267,094.00

2.30%

¦è³¡

    5,870,499.00

9.30%

¥þ°ê

   11,898,828.00

4.20%

               ¾Ö¦³³Ì¦h¨È¸Çªº¦{

¥[¦{

    4,155,685.00

¡@

¯Ã¬ù

    1,169,200.00

¡@

®L«Â¦i

       703,232.00

¡@

¼w¦{

       644,193.00

¡@

¯Ã¿A¦è

       524,356.00

¡@

           ¨È¸Ç¤ñ¨Ò³Ì°ª,¤H¤f¶W¹L10¸U

®L«Â¦i

67.7%

¡@

¥[¦{»X¯S¤O

53.60%

¡@

¥[¦{µá»X¯S

39.80%

¡@

¥[¦{®á¥§¬°º¸

34.20%

¡@

ª÷¤s

32.60%

¡@

           ¤H¤f³Ì¦hªº¨È¸Ç±Ú¸s

µØ¸Ç

    2,734,841.00

¡@

µá«ß»«¤H

    2,364,815.00

¡@

¦L«×

    1,899,599.00

¡@

Áú°ê

    1,228,427.00

¡@

¶V«n

    1,223,736.00

¡@

 ¦pªG¨Ì¤H¤f¼Æ¶q¿Å¶q¥«³õ¤j¤p,¬ù¦³¥b­Ó¥xÆW¥«³õ¤j.,¦ý¬O¦³¤@­«ÂI¬O¦b³o­Ó°Ï°ì, ¥X¤f¼t°Ó¥iª½±µ¶}µoµá«ß»«¤H,¶V«n¤H,Áú°ê¤Hµ¥¼ç¦b¥«³õ¦Ó¤£¶·¹ï¨ä©ÒÄݰê®a¤@¤@¶}µo. ¤@ºô¥´ºÉ¬O¥D­n¥Ø¼Ð. ¦^¥D­¶

 ¼t°Ó¹ï¥~¾P®É±`·|¥Çªº¿ù»~:

ªñ¨Ó¦]°ê¤º¤j«¬³q¸ôªºÂX±i,¨Ï³\¦h¤¤¤p«¬­¹«~¼t°Ó­¿·PÀ£¤O, ¦b°ê¥~¥ç¬O¦p¦¹..¹ï§Ü±j¶Õ³q¸ôªº¤è¦¡´N¬O±j¶Õ«~µP, ¦p¦ó°µ ? ­«ÂI´N¬OÃö¤ß¦Û¤v,

¦pªG§â²£«~·í§@¦Û¤vªº¤p«Ä, ¦pªG¤p«Ä¨ì¬ü°ê©À®Ñ, °µ®aªøªºÁ`·|¥´­Ó¹q¸Ü°Ý¦Yªº¦n¤£¦n? ¥h¹L¨º¸Ìª±µ¥°ÝÃD. ²£«~¤]¬O¦p¦¹,³Q½æ¨ì¨º¸Ì ? ¹s°â»ù¦p¦ó?®w¦s¦h¤Ö ³o¨Ç³£¬O¼t°Ó¦³Åvª¾¹Dªº, ¶i¤f°Ó©Î¥N²z°Ó³£¦³¸q°È§i¶D§A.

¦pªG¹ï¦Û¤vªº²£«~¤£»D¤£°Ý,¥u¥H¶q¨Ó¿Å¶q, ²£«~¥u·|¦¨¬°¶T©ö°Ó,³q¸ô°Ó¤Î¶i¤f°Óªº¤l¼u, ¥ÎºÉ«á¿ò±ó, ±N¨Ó¥u·|³Q­¢²^¨O. ¦]¬°¨S¦³²£«~¬O¤£¥i¨ú¥Nªº,¥u¦³«~µP¤£¬O.  

¤­¤j¤£ª¾:

1.¤£ª¾¹D¥½ºÝ«È¤á¬O½Ö.....................·í¶T©ö°ÓÂà³æ®É,¤~µo²{¦M¾÷.

2.¤£ª¾¹D¶T©ö°Ó/¶i¤f°Ó¦p¦ó¦æ¾P....¤]³\§Aªº²£«~¤w³Q¥é«_,

3.¤£ª¾¹D²£«~¥½ºÝ°â»ù......................¤]³\§Aªº²£«~¥¿¦b½â½æ¤¤

4.¤£ª¾¹D²£«~¥½ºÝÁʶR±Ú¸s..............¦Ñªº ¤Öªº ¥Õ¤H ¶V«n¤H ?

5.¹ïFDAªº³W©w¤@ª¾¥b¸Ñ..................FDA»{¥¿ ? «D±`¿ù»~ªº»¡ªk

  ¹ï¥«³õ¤@ª¾¥b¸Ñ³Ì¤jªº¦MÀI¬O®e©ö³Q¶T©ö°Ó¤Î¶i¤f°Ó ¡§°ä¡¨, ¤£ºÞ¦b¼Æ¶q¤W¦b¶T©ö°Ó¤Î¶i¤f°Ó¥»¨­ªº³W¼Ò¤W³£®e©ö»~§P. ´X¦~«e¤@®a¥xÆWª¾¦W«~µP¦]¬üªF¤Î¬ü¦èªº¶i¤f°Ó³£µªÀ³¸g¾P¤@­ÓÁ`¶q»·¶W¹L¥xÆW¥»®qªº¾P¶q, ¤u¼t¥»¨­©¿²¤¤F¬ü°ê¨È¸Ç¤H¤fµ²ºc, ·í®Éªgªg¦Û³ß,¦ý°¨¤W¥«³õ®ø¤Æ¤£¨}, ¬ü¦è¥N²z§â³f¾P©¹¬üªF«I¥Ç¥N²z°Ï°ì.³y¦¨¦Û¤v½Ð§O¤H®³¥ÛÀY¥´¦Û¤vªº±¡ªp. µ²ªG¬O, ²£«~Åܦ¨°­¨£·T.¤£¤[´N³Q¨ä¥L²£«~¨ú¥N.¦^¥D­¶

  ¬ü°êµØ¤H¶i¤f°ÓºD¥Îªº­p¶q

 ·í¦³¦h®a¶i¤f°Ó©Î¶T©ö°Ó³£ª§¬Û±ÄÁʧA©Ò¥Í²£ªº²£«~®É,½Ð¤£­nªgªg¦Û³ß, ¦]¬°¦M¾÷¤~¶}©l.  §Ú­Ì¥Î³Ì²³æªº¤è¦¡¨Ó«ä¦Ò, ·í¨C¤@®a³£­°1¤¸®É, ¹L¤£¤F¦h¤[½æ»ù´N±µªñ¦¨¥». ³o®É, µ´©Û´N¨Ï¥X¨Ó¤F..........¨ä¤¤¤@®a¤jÁx¦³ºØªº¶i¤f°Ó©Î¶T©ö°Ó´N·|¨ì¤j³°©Î¨ä¥L¦¨¥»§Cªº¦a¤è¥h°µ¥é«_«~. 

·í¥é«_«~¶i¤J¥«³õ®É, ·|¦³¨âºØ¨«¶Õ : 1.¨ä¥L¶i¤f°Ó©Î¶T©ö°Ó´N·|¹ï¼t°Ó¤£½Ì¸Ñ, ¦]¬°¥é«_ªÌªº»ù®æ§C©ó¦¨¥», ¦X²zªº·|ÃhºÃ¼t°Ó¿W´f¨ä¤¤¤@®a, ´N¦¹°±¤î¶i³f. 2. ·í¨ä¥L¤H³£°h¥X¥«³õ®É, §Aªº³f´N³Q¥é«_ªÌ±±¨î, «áªG½Ð¦Û¦æ¤ÀªR¡D¦^¥D­¶

¥xÆW»PªF«n¨È¤Î¤j³°²£«~ªº¤ñ¸û

¥Ø«e¤j³°²£«~»P¥xÆW³fªº¦P½è©Ê³Ì°ª¤]³Ì¾Ú«Â¯Ù©Ê¡C¤£¥u³o¨Ç¡A³s¾P°â¤è¦¡¤Î«ä¸ô¤]»P80¢Hªº¼t°Ó¤@¼Ë¡C¤j®a³£¦b°µ ¡¨½æ¡¨ ªº°Ê§@.

¥xÆW¼t°Ó·|½æ, ¤j³°¤ÎªF«n¨È¼t°Ó¤ñ§Ú­Ì§ó·|½æ,»ù®æ§ó§C, ¤ñ»ù®æ§Ú­Ì¤@©wµLªkÄvª§, ©Ò¥H«Ø¥ß«~µP¬O¤£¤Gªk«h.

ªF«n¨È¦U°ê¦]¬°ªÀ·|µ²ºcªºÃö«Y,³\¦h¤u¼tºÞ²z¶¥¼h³£±µ¨ü¦è¤è±Ð¨|,¥L­Ì©Ò³]­p¥X¨Óªº¥]¸Ë¤Î²£«~¤ñ¥xÆW²£«~§ó®e©ö¥´¤J¥Õ¤H¥«³õ.¦^¥D­¶

«~µP¦æ¾P ? ¤p¼t¥i¥H¶Ü ?

  20¦~«e³\¦h¥xÆW¼t°Ó¦b¥X¤f¤W±Ä¨ú¦@¾P¨î,´N¬O½Ö¨Ó§Ú³£½æ, ¦ý¬Oµoıªñ¦~¨Ó«È¤á¦h¨Ã¤£¥Nªí¼Æ¶q¼W¥[, ¬°¤°»ò ? ­ì¦]¦³¤T:

1.¦­¦~¶i¤f°Ó¼Æ¶q¤Ö, ¥[¤W°Ï°ì¤j °ò¥»¤WµL¬Û¤¬­«Å|

2.¥xÆW¦b¨È¸Ç­¹«~¬É¦]¬F©²ªº»²¾É¬Fµ¦¦û¦³»â¾É¦a¦ì, ¦ýªñ¨ÓªF«n¨È¤Î¤j³°ªº±¸°_,¤À­¹¤F¥«³õ.

3.­«ÂI¬O¦]¦h¤H¸g¾P¦P¤@²£«~, µL¤H¸gÀç«~µP ¾É­P·s«~¥F¤H°Ý¬z«~³QªF«n¨È¤Î¤j³°´À¥N.ªºµ~¹Ò.

¬ü°ê¬O¤@­Ó°ª«×Ävª§ªº¥«³õ, ¥ô¦ó«~µP³£µLªk¥H¦b©ÒÄݰꪺÀu¶Õ¨Ó§P©w¤@©w¨üÅwªï. ¨Ò¦p : ¯Ã¬ù¥Ø«e¦³¤@«~µP ¡§¤tÅQ¤ý¡¨ ¤j®a¬O§_Å¥¹L ? ¡§ª÷ÄQÅ ¬O§_ª¾¹D¦b½æ¤°»ò²£«~? ¤Ï¹L¨Ó§A°Ý¤@­Ó¶V«n¤H¡¨¶}³ß¡¨ ¬O§_Å¥¹L?§Ú¬Û«Hµª®×¬O§_©wªº.

­«ÂI¬O¡A¤£ºÞ«~µPªº¤j¤p¥u­nªÖ°µ«~µP¦æ¾P³£¦³¥i¯à¦¨¬°¤jµP¤l.¦^¥D­¶

¥D¬y¥«³õ

¦b¬ü°ê´¶¹Mªº±¡ªp¬O®õ°ê¤Î¦L«×»¶´ÔÂæ¥i¶i¤J¬ü°ê¶W¥«¦ýµ´¹ï¬Ý¤£¨ì¥xÆW©Î¤j³°ªº²£«~¡A¨ä¤¤­ì¦]¦³¤f¨ý¡B¥]¸Ë¤£¾A¦X¥Õ¤H¡A¦ý³Ì¤jªº°ÝÃD¬O¡A²£«~¤@¥X¤f´N¨ìµØ¤H¥«³õ¥H §C»ù ¥X°â¡A½ü¬°¶i¤f§åµo°Óªº±a¸ô³f¡A¨Ï¥Õ¤H¥D¬y¥«³õ¦]µLªkÄvª§¦Ó³Q­¢©ñ±ó¡C

¦³®É¼t°Ó¥H¥xÆWªºÆ[ÂI¨Óµû¦ô¶R¤èªº¹ê¤O¡A©¿²¤¤Fªø»·ªº§Q¯q¡C¦]¬°µØ¤H¶W¥«ªº³W¼Ò»·¤£¤Î¥Õ¤H¥D¬y¶W¥«¡A¼t°Ó¤d¸U¤£­n¥H¬°³o®a¶W¥«¶i¤F§Aªº³f«á´N¤£·|¦A¶i¨ä¥L¥xÆW¹ï¤â©Î¤j³°¹ï¤âªº³f¡A¬Û¤Ïªº¡A¥Õ¤H¥D¬y¶W¥«³õªº©¾¸Û«×°ªªº³\¦h¡C

¤@¯ë¥Õ¤H¶W¥«¬°¤F·ÓÅU¥L­Ìªº¤Ö¼Æ¥Á±Ú«È¤á·|±ÄÁʪF¤è­¹«~, ¦ý¦³¨â­Ó­«­n¦Ò¶q : ¤@. ¥²»Ý¦bªF¤è¥«³õ¦³¤@©wªº¦W®ð, ¤G.»ù®æ¥²»Ý¥i¥HÄvª§. 

¥D¬y¶W¥«¤@¯ë¤£¦Û¤v¶i¤f, ±Mªù¸gÀç "¤Ö¼Æ¥Á±Ú"­¹«~ªºBroker ©Î¤¤½L°Ó¥h "¥]¬[." ´N¬O¾ã­Ó³f¬[¥Ñ³o­ÓBroker ©Î¤¤½L°Ó¥h¥I³d¤W³f,½LÂI¤Î¦V¶i¤f°Ó¶i©Ò¦³¦L«×,µØ¤H,Áú°ê,¤é¥»µ¥¤Ö¼Æ¥Á±Ú­¹«~, ·N«ä¬O : ·í§Aªº²£«~¸g¹L¶i¤f°Ó--->¤¤½L°Ó--->¶W¥«--->®ø¶OªÌ «á,²£«~»ù®æ¤w¬O40%-50%°ª©óFOB»ù. 

¦ý¬OµØ¤H¶W¥«ª½±µ©Î³z¹L¶i¤f°Ó¶i³f,¦A¥[¤W§C§Q¼í¨î«×,³Ì«á»ù¥u¬O15-20%°ª©óFOB»ù. ´N¬O¦]¬°³o¼Ëªº»ù®æ®t¶Z,¥Õ¤H¥D¬y¶W¥«´N·|©ñ±ó¶Q¼tªº²£«~. ¦ý¤]³\§A·|»¡ : ¨S®t,¤Ï¥¿§Úªº²£«~¦Ñ¥~¤£¦Y. ¦ý¬O½Ð¤£­n§Ñ°O, ¥u­n¤W¤F¬[,Á`¬O¦³¾÷·|ªº. ¦^¥D­¶ 

­¹«~¤u·~=¤i¶§¤u·~ ? 

³\¦h¼t°Ó·í®É§ë¸ê³]³Æ®É³£§Æ±æ³o®M³]³Æ¯à20¦~30¦~¤£¥²´«.¦ý¬O¥i¯à¹À ? ·í§A­Ì¤u¼tªº³]³Æ¤ñ®aùتº¸ËæCÁÙ¯}ªº®É­Ô,¬O§_¦³·Q¹L¬O½Ö¥I¤F³o¨Ç¸ËæC. ·í¬F©²«Å¾É²£·~¤É¯Å®É, §Úªº«ØÄ³¬OÀY¸£¤É¯Å. ¤ñ ¦p»¡: ¤@®a¦Ì¯»¼t30¦~«e·íªìªº§ë¸ê¬O¥x¹ô100¸U,¨C5¨ì10¦~¤É¯Å§ó·s¤@¦¸³]³Æ,¨ì²{¦b¤]³\§Aªº³]³Æ¤w¹F¨ì¥x¹ô500¸U¥H¤W, ¸Õ·Q²{¦b¦³¤H·|§ë¸ê500¸U¨Ó¶i¤J¦Ì¯»³o¦æ¹À ?

¦Ó¥B³]³Æ§ó·s¬O´î¤Ö¤H¤O¼W¥[²£¶qªº¤è¦¡, ¦U¦ì¬O§_·Q¹L¬°¤°»ò¤é¥»­¹«~ÁÙ¥i¥H½æ¨ì¥xÆW¤Î¥@¬É¦U¦a ? ·íµM¬O¾a³]³Æ. ¦^¥D­¶ 

FDA

½Ðª`·N¥H¤U¬°FDAªºÁn©ú.

FDA does not certify products manufactured in countries outside the United States. FDA does not "approve" individual manufacturers. FDA does not pre-approve shipments for importation into this country. At the time of importation, FDA may collect samples to analyze for compliance with the food additive regulations of this country.
There are no charges for FDA examinations of import samples. The agency does not accept pre-import samples or issue import licenses. The food additive regulations are the same for products manufactured in the United States (U.S.) or imported into this country.

­¹«~»PÃĪ«ºÞ²z§½¤£ÃÒ©ú¦b¬ü°ê¤§¥~°ê®a»s§@¥Í²£ªº産«~¡C

­¹«~»PÃĪ«ºÞ²z§½" ¤£§å­ã" ¿W¥ßªº»s³y°Ó¡C

­¹«~»PÃĪ«ºÞ²z§½¤£¹w¥ý§å­ã¥¼¶i¤fªº³f¡C

¦b¶i¤f¤§®É, ­¹«~»PÃĪ«ºÞ²z§½¤]³\·|¦¬¶°¼Ë«~,¤ÀªR³o­Ó°ê®aªº¬O§_²Å¦X¬ü°êªº­¹«~²K¥[¾¯³¹µ{¡C

¦¬¶°¼Ë«~,¤ÀªR¬O¤£¦¬¶Oªº¡C

­¹«~»PÃĪ«ºÞ²z§½¤£±µ¨ü¹w¥ýªº¶i¤f¼Ë«~©Îµo§G¶i¤f°õ·Ó¡C­¹«~²K¥[¾¯³¹µ{¦P¼Ë¾A¥Î¦b¬ü°ê»s§@ªº産«~

HACCP

In response to your inquiry, FDA does not assign any  laboratory or institution to help foreign processors  obtain HACCP  certification and does not certify HACCP plans.  
It is the processor's responsibility to provide  food that  meets United States regulations.  All processors of  fish and fishery  products, as defined by the regulation 21 CFR, Part 123, "Procedures for the  Safety and Sanitary Processing and Importing of Fish  and Fishery Products"  must perform a hazard analysis, and must develop and  implement a Hazard  Analysis Critical Control Point (HACCP) plan that  addresses all of the  hazards that the hazard analysis identifies as  reasonably likely to occur. 
A HACCP trained individual must perform the hazard  analysis initially and  need not be an employee of the processor.
FDA would not object to grouping products in one  HACCP plan  that have the same hazards and controls.
It is unclear whether you are an importer or  foreign  processor.  Importers also have special requirements  as defined by the  regulation 21 CFR, Part 123.12.
If you have access to the Internet, you may wish  to visit  our website at www.fda.cfsan.gov.  and look at the  topics related to Seafood,  HACCP, Imports and  Exports which can provide  guidance.  Also, you can  consult FDA's "Fish and Fisheries Products Hazards  and Controls Guidance"  manual which can provide processors with a good  understanding of hazards  that are reasonably likely to occur in seafood  products and the kinds of  controls that would be acceptable to FDA.    


¡@